Richard Pascoe

Track

Insider profile

Currently holds positions in Seelos Therapeutics Inc and Zevra Therapeutics Inc

Performance

Overall performance
2.0
Performance over holding periods
2.0
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 14% 68% 82%
Transactions
3 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director Seelos Therapeutics Inc Jan. 24, 2019 -
Lead Independent Director Zevra Therapeutics Inc Nov. 1, 2014 -
Chief Executive Officer, Principal Accounting Officer, Secretary, Director Seelos Therapeutics Inc Dec. 1, 2016 - Jan. 24, 2019
Chief Executive Officer, Secretary, Director Seelos Therapeutics Inc Feb. 1, 2015 - Dec. 1, 2016
Chief Executive Officer, Director Seelos Therapeutics Inc March 1, 2013 - Feb. 1, 2015
Chief Executive Officer, Director Seelos Therapeutics Inc March 18, 2013 - Feb. 1, 2015
Independent Director Zevra Therapeutics Inc Jan. 1, 2014 - Nov. 1, 2014
Richard Pascoe's trades of Seelos Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
68.33
Quantity 8,951 +8.1%
Value US$1,100,625
Transaction date
Purchase
Price
56.18
Quantity 30,936 -4.5%
Value US$438,259
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2014-12-22 2014-12-22
B Purchase
8,951 +8.1%
68.33
US$1,100,625 		8,951 +8.1% 68.33 US$1,100,625
2014-10-24 2014-10-22
B Purchase
30,936 -4.5%
56.18
US$438,259 		30,936 -4.5% 56.18 US$438,259
2013-05-24 2013-05-23
B Purchase
83,200 +11.4%
308.33
US$1,630,537 		83,200 +11.4% 308.33 US$1,630,537